340B Contract Pharmacy Restrictions Slowed Program’s 2021 Spending Trajectory, But Not Much

 
• By Cathy Kelly

Manufacturer restrictions on discounts to contract pharmacies may have depressed sales for 340B-discounted diabetes drugs in 2021. But sales in other categories, including oncology, immunology and arthritis drugs, were up by 20% to 40%.

2021 Was First Full Year Of contract pharmacy Restrictions, but the Future Impact Likely will Be More Pronounced. • Source: Shutterstock

More from Market Access

More from Pink Sheet